BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11604230)

  • 1. Specific DNA binding and transactivation potential of recombinant, purified Stat5.
    Beisenherz-Huss C; Mundt M; Herrala A; Vihko P; Schubert A; Groner B
    Mol Cell Endocrinol; 2001 Oct; 183(1-2):101-12. PubMed ID: 11604230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
    Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N; Matsuda T
    J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
    Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.
    Valgeirsdóttir S; Paukku K; Silvennoinen O; Heldin CH; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(4):505-15. PubMed ID: 9484840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
    Gouilleux F; Wakao H; Mundt M; Groner B
    EMBO J; 1994 Sep; 13(18):4361-9. PubMed ID: 7925280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G; Yu-Lee L
    J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
    Groner B; Fritsche M; Stöcklin E; Berchtold S; Merkle C; Moriggl R; Pfitzner E
    Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S15-20. PubMed ID: 10984248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
    Park SH; Yamashita H; Rui H; Waxman DJ
    Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
    Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
    Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
    Friedrich K; Wietek S
    Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic residues Phe751 and Leu753 are essential for STAT5 transcriptional activity.
    Callus BA; Mathey-Prevot B
    J Biol Chem; 2000 Jun; 275(22):16954-62. PubMed ID: 10748177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
    Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
    Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.
    Gouilleux F; Pallard C; Dusanter-Fourt I; Wakao H; Haldosen LA; Norstedt G; Levy D; Groner B
    EMBO J; 1995 May; 14(9):2005-13. PubMed ID: 7744007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.